MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma

Clinical Cancer Research

Volumn 15, Issue 8, 2009, Pages 2850-2855

  Avissar, Michele ^a   Christensen, Brock C ^a,b   Kelsey, Karl T ^a,b   Marsit, Carmen J ^a,c  

^a Department of Pathology ^*  (United States)

^b BROWN UNIVERSITY   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; EPITHELIAL CELLS; HEAD AND NECK NEOPLASMS; HUMANS; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 65249186738     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-3131     Document Type: Article

References (42)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001;2:533-43.
2. Ragin CC, Modugno F, Gollin SM. The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus. J Dent Res 2007;86:104-14.
3. Loning T, Ikenberg H, Becker J, et al. Analysis of oral papillomas, leukoplakias, and invasive carcinomas for human papillomavirus type related DNA. J Invest Dermatol 1985;84:417-20.
4. Furniss CS, McClean MD, Smith JF, et al. Human papillomavirus 16 and head and neck squamous cell carcinoma. Int J Cancer 2007;120:2386-92.
5. Hardisson D. Molecular pathogenesis of head and neck squamous cell carcinoma. Eur Arch Otorhinolar-yngol 2003;260:502-8.
6. Al Moustafa AE, Alaoui-Jamali MA, Batist G, et al. Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene 2002;21:2634-40.
7. Schlecht NF, Burk RD, Adrien L, et al. Gene expression profiles in HPV-infected head and neck cancer. J Pathol 2007;213:283-93.
8. Pyeon D, Newton MA, Lambert PF, et al. Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. Cancer Res 2007;67:4605-19.
9. Blenkiron C, Miska EA. miRNAs in cancer: approaches, aetiology, diagnostics and therapy. Hum Mol Genet 2007;16 Spec No 1:R106-13.
10. Bunz F, Dutriaux A, Lengauer C, et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998;282:1497-501.
11. Cowland JB, Hother C, Gronbaek K. Micro RNAs and cancer. APMIS 2007;115:1090-106.
12. Du T, Zamore PD. Beginning to understand micro-RNA function. Cell Res 2007;17:661-3.
13. Miska EA. How micro RNAs control cell division, differentiation and death. Curr Opin Genet Dev 2005;15:563-8.
14. He H, Jazdzewski K, Li W, et al. The role of micro-RNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A 2005;102:19075-80.
15. Murakami Y, Yasuda T, Saigo K, et al. Comprehensive analysis of micro RNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006;25:2537-45.
16. Lu J, Getz G, Miska EA, et al. Micro RNA expression profiles classify human cancers. Nature 2005;435:834-8.
17. Chang SS, Jiang WW, Smith I, et al. Micro RNA alterations in head and neck squamous cell carcinoma. Int J Cancer 2008;123:2791-7.
18. Tran N, McLean T, Zhang X, et al. Micro RNA expression profiles in head and neck cancer cell lines. Biochem Biophys Res Commun 2007;358:12-7.
19. Volinia S, Calin GA, Liu CG, et al. A micro RNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006;103:2257-61.
20. Guo Y, Chen Z, Zhang L, et al. Distinctive micro RNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res 2008;68:26-33.
21. Iorio MV, Visone R, Di Leva G, et al. Micro RNA signatures in human ovarian cancer. Cancer Res 2007;67:8699-707.
22. Blenkiron C, Goldstein LD,Thorne NP, et al. Micro-RNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol 2007;8:R214.
23. Peters ES, McClean MD, Liu M, Eisen EA, Mueller N, Kelsey KT. The ADH1C polymorphism modifies the risk of squamous cell carcinoma of the head and neck associated with alcohol and tobacco use. Cancer Epidemiol Biomarkers Prev 2005;14:476-82.
24. Marsit CJ, Eddy K, Kelsey KT. Micro RNA responses to cellular stress. Cancer Res 2006;66:10843-8.
25. Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 2002;18 Suppl 1:S96-104.
26. Chen C, Ridzon DA, Broomer AJ, et al. Real-time quantification of micro RNAs by stem-loop RT-PCR. Nucleic Acids Res 2005;33:e179.
27. Gordon GJ, Jensen RV, Hsiao LL, et al. Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma. Cancer Res 2002;62:4963-7.
28. Pan W. A comparative review of statistical methods for discovering differentially expressed genes in replicated microarray experiments. Bioinformatics 2002;18:546-54.
29. Szafranska AE, Davison TS, John J, et al. Micro RNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 2007;26:4442-52.
30. Cho WC. Oncomi Rs: the discovery and progress of micro RNAs in cancers. Mol Cancer 2007;6:60.
31. Yanaihara N, Caplen N, Bowman E, et al. Unique micro RNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006;9:189-98.
32. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH. Programmed cell death 4 (PDCD4) is an important functional target of the micro RNA miR-21 in breast cancer cells. J Biol Chem 2008;283:1026-33.
33. Zhu S, Si ML, Wu H, Mo YY. Micro RNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 2007;282:14328-36.
34. Fornari F, Gramantieri L, Ferracin M, et al. MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene 2008;27:5651-61.
35. Galardi S, Mercatelli N, Giorda E, et al. miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem 2007;282:23716-24.
36. Nam EJ, Yoon H, Kim SW, et al. Micro RNA expression profiles in serous ovarian carcinoma. Clin Cancer Res 2008;14:2690-5.
37. Takakura S, Mitsutake N, Nakashima M, et al. Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells. Cancer Sci 2008;99:1147-54.
38. Poy MN, Eliasson L, Krutzfeldt J, et al. A pancreatic islet-specific micro RNA regulates insulin secretion. Nature 2004;432:226-30.
39. Kloosterman WP, Lagendijk AK, Ketting RF, Moulton JD, Plasterk RH. Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development. PLoS Biol 2007;5:e203.
40. Ladeiro Y, Couchy G, Balabaud C, et al. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 2008;47:1955-63.
41. Johnson SM, Grosshans H, Shingara J, et al. RAS is regulated by the let-7 micro RNA family. Cell 2005;120:635-47.
42. Gomes CC, Gomez RS. Micro RNA and oral cancer: future perspectives. Oral Oncol 2008;44:910-4